Clopidose trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14751416

Enrollment

150

Registered

2006-01-27

Start date

2005-12-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular outpatients Circulatory System

Interventions

After a loading dose of clopidogrel (600 mg), patients will take a standard dose of clopidogrel 75 mg once a day for 15 days. At day 15, adenosine diphosphate (ADP) induced platelet aggregation and m

Eligibility

Inclusion criteria

Inclusion criteria: Cardiovascular outpatients on 75 mg/day clopidogrel

Exclusion criteria

Exclusion criteria: Anticoagulation

Design outcomes

Primary

Measure	Time frame
Biological effect of clopidogrel	—

Secondary

Measure	Time frame
Genetic association study	—

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026